Old Dominion Capital Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$511K Sell
11,875
-511
-4% -$22.6K 0.11% 118
2021
Q2
$485K Sell
12,386
-954
-7% -$37.1K 0.1% 121
2021
Q1
$483K Buy
13,340
+8
+0.1% +$284 0.11% 118
2020
Q4
$491K Sell
13,332
-161
-1% -$5.91K 0.12% 112
2020
Q3
$470K Buy
13,493
+3,583
+36% +$126K 0.13% 103
2020
Q2
$307K Sell
9,910
-7,343
-43% -$249K 0.1% 124
2020
Q1
$534K Sell
17,253
-865
-5% -$29.5K 0.22% 83
2019
Q4
$674K Sell
18,118
-312
-2% -$11.1K 0.22% 88
2019
Q3
$628K Sell
18,430
-663
-3% -$24.1K 0.21% 97
2019
Q2
$785K Sell
19,093
-74
-0.4% -$2.94K 0.27% 86
2019
Q1
$753K Sell
19,167
-3,079
-14% -$123K 0.26% 85
2018
Q4
$921K Buy
22,246
+4,623
+26% +$192K 0.33% 82
2018
Q3
$737K Buy
17,623
+7,030
+66% +$271K 0.22% 93
2018
Q2
$365K Buy
10,593
+796
+8% +$27.2K 0.33% 53
2018
Q1
$330K Buy
9,797
+3,494
+55% +$120K 0.31% 56
2017
Q4
$217K Buy
+6,303
New +$215K 0.21% 55

Other funds holding PFE

Old Dominion Capital Management's PFE Position: Q3 2021 in Review

Old Dominion Capital Management reduced its Pfizer (PFE) stake by 4.1% in Q3 2021, selling an estimated $22.6K and leaving 11,875 shares worth $511K. The position accounts for 0.11% of the portfolio, ranked #118.

Old Dominion Capital Management first reported a position in PFE in Q4 2017 and has held it in 16 quarters since. The position peaked at $921K in Q4 2018. 2,803 funds tracked by Wall St. Rank hold PFE as of Q3 2021.

  • Old Dominion Capital Management held 11,875 shares of Pfizer worth $511K as of Q3 2021.
  • Old Dominion Capital Management sold 511 Pfizer shares in Q3 2021, an estimated $22.6K.
  • Pfizer made up 0.11% of Old Dominion Capital Management's portfolio in Q3 2021, its #118 holding.
  • Old Dominion Capital Management first reported a position in Pfizer in Q4 2017 and has held it in 16 quarters since.
  • Old Dominion Capital Management's Pfizer position peaked at $921K in Q4 2018.
  • 2,803 funds tracked by Wall St. Rank held Pfizer as of Q3 2021.

Based on Old Dominion Capital Management's 13F filing for Q3 2021, filed 8 Oct 2021.